1 / 14

Heat Shock Proteins and their Role in Thermal Therapies

Heat Shock Proteins and their Role in Thermal Therapies. Shawn Keating MPB 1028 Presentation September 21, 2010. Outline. Heat shock proteins (HSP’s) Description and family members Mechanism of action Role in Thermal Therapies Dichotomy of Treatment Approaches

quilla
Télécharger la présentation

Heat Shock Proteins and their Role in Thermal Therapies

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Heat Shock Proteins and their Role in Thermal Therapies Shawn Keating MPB 1028 Presentation September 21, 2010

  2. Outline • Heat shock proteins (HSP’s) • Description and family members • Mechanism of action • Role in Thermal Therapies • Dichotomy of Treatment Approaches • Inhibition of HSP’s for tissue destruction • Up-regulation for immuno-modulation • Examples of treatments • References

  3. What are HSP’s? • A family of proteins that are basally expressed in the ER, cytosol, mitochondria and nucleus of all cells. In normal conditions they function to: • Stabilize pre-folded/unfolded proteins for proper final folding. • Target proteins to lysosome/ proteosome for degradation. • Chaperone proteins to ER and other organelle for operation once translated.

  4. Major targets for therapy Rylanderetal., 2005

  5. What are HSP’s (Cont’d) • Under conditions of stress (hyperthermia, oxidative, ischemia, heavy metals, inflammation) their expression is up-regulated through transcription factors and their role in the cell extends to: • Binding of denatured proteins to prevent aggregation and to assist in refolding. • Inhibit apoptosis by upregulating NO production. • Immunomodulation by assisting in antigen presentation.

  6. HSP Mechanism • How exactly HSP’s are able to retain function under conditions of stress is a contentious issue but their improved stability under heating is generally accredited to: • Increased hydrogen bonding • Tighter hydrophobic internal packing HSP- 60 Chaperonin HSP-70 DnaK

  7. Role 1 in Thermal Therapies • HSP’s are up-regulated in tumour cells. -their protective effects confound thermal therapies. Inhibition is one solution. Rylanderetal., 2005

  8. Example • Inhibition of HSP-90 with geldonamycin (GA) for treatment of melanoma. Control Hyper GA Both Ito et.al,2009

  9. Role 2 in Thermal Therapies • HSP’s play a role in immuno-modulation: - they act to chaperone proteins to the ER for MHC I presentation to cytotoxic T-lymphocytes (CTL’s) and macrophage cells. - extracellular HSP’s can assist in antigen presentation to professional antigen presenting cells for stimulation of the adaptive immune response. Torigoeetal., 2009

  10. Example • HSP vaccinations - combining hyperthermia with HSP vaccinations extracellularly could potentially increase adaptive immune response to cancer specific antigens. - By presenting antigens to CTL’s, the adaptive arm of the immune system is stimulated allowing long term resistance to cancer reoccurrence.

  11. Example (cont’d) Torigoe et.al., 2009

  12. Role 3 in Thermal Therapy • HSP’s can inhibit apoptosis - immediately through suppression of apoptotic signals. - long term by assisting in refolding of denatured proteins.

  13. Example • Anti-apoptotic signalling from hyperthermia induced HSP-72 expression increases oncolytic herpes virus replication and leads to increased tumour killing. Eisenberg etal., 2010

  14. References • Calderwood SK, Ciocca DR. 2008. Heat Shock Proteins: Stress proteins with Janus-like properties in cancer. Int. J. Hyperthermia 24: 31-39. • Eisenberg DP, Carpenter SG, Adusumilli PS, Chan M-K, Hendershott KJ, Yu Z, Fong Y. 2010. Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway. Surgery 148:325-34. • Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. 2002. The cellular and molecular basis of hyperthermia. Crit. Rev. Onc/Hem. 43: 33-56. • Ito A, Saito H, Mitobe K, Minamiya Y, Takahashi N, Maruyama K, Motoyama S, Katavose Y, Ogawa J. 2009. Inhibition of heat shock protein 90 sensitizes melanoma cells to thermosensitive ferromagnetic particle-mediated hyperthermia with low Curie temperature. Cancer Sci. 100: 558-564. • Manjili MH, Wang X-Y, Park J, Macdonald IJ, Li Y, Van Shie RCAA, Subjeck JR. 2002. Cancer Immunotherapy: stress proteins and hyperthermia. Int. J. Hyperthermia 18: 506-520. • Rylander MN, Feng Y, Bass J, Diller K. 2005. Thermally Induced Injury and Heat Shock Protein Expression in Cells and Tissues. Ann. N.Y. Acad. Sci. 1066: 222-242. • Torigoe T, Tamura Y, Sato N. 2009. Heat shock proteins and immunity: Applications of hyperthermia for immunomodulation. Int. J. Hyperthermia 25: 610-616.

More Related